The metabolism of cysteine and cysteinesulphinate was studied in freshly isolated rat hepatocytes. Over 80O% of the 14CO2 formed from [1-14C]cysteinesulphinate could be accounted for by production of hypotaurine plus taurine in incubations of rat hepatocytes with either 1 mm-or 25 mM-cysteinesulphinate. In similar incubations with 1 mm-or 25 mM-cysteine, less than 10% of 14CO2 evolution from [1-14C]cysteine could be accounted for by production of hypotaurine plus taurine. In incubations with cysteine, but not with cysteinesulphinate, the production of urea and ammonia was substantially increased above that observed in incubations without substrate. Addition of unlabelled cysteinesulphinate did not affect 14C02 production from [1-14C]cysteine. Addition of 2-oxoglutarate resulted in a marked increase in cysteinesulphinate catabolism via the transamination pathway, but addition of neither 2-oxoglutarate nor pyruvate to the incubation system had any effect on cysteine catabolism. Inhibition of cystathionase with propargylglycine decreased 14CO2 production from [1-14C]cysteine about 50% and markedly decreased production ofammonia plus urea N; cysteinesulphinate catabolism was not affected. These data suggest that a substantial proportion of cysteine is catabolized by cysteinesulphinate-independent pathways in the rat hepatocyte and, furthermore, that cleavage of cyst(e)ine by cystathionase may be an important physiological pathway for cysteine catabolism in rat liver.
INTRODUCTION
One pathway of cysteine metabolism involves its oxidation to cysteinesulphinate, followed either by decarboxylation of cysteinesulphinate to hypotaurine, which is further oxidized to taurine, or by transamination of cysteinesulphinate to yield 3-sulphinylpyruvate, which spontaneously decomposes to yield pyruvate and sulphite (Stipanuk, 1986 ) (see Scheme 1). Estimates based on measurements of 14CO2 expiration by intact male rats given 1-14C-or 3-14C-labelled cyst(e)ine or cysteinesulphinate suggested that about 80% of cysteine or cysteinesulphinate catabolism in the rat leads to taurine production (Yamaguchi et al., 1973; Stipanuk & Rotter, 1984) , and these estimates have led to an assumption that most cysteine catabolism involves intermediate formation of cysteinesulphinate. In apparent conflict with the thesis that the rat converts most cysteine into taurine, rats excreted 70-80% of cysteine sulphur as sulphate rather than as taurine (Krijgsheld et al., 1981 ; Daniels & Stipanuk, 1982) . Studies of taurine degradation indicated that only a small proportion of the excreted sulphate is likely to have resulted from taurine degradation by intestinal micro-organisms (Hepner et al., 1973) .
Although formation of either taurine or sulphate from cysteine may occur after formation of cysteinesulphinate, several observations suggest that cysteinesulphinateindependent pathways also play an important role in cysteine metabolism in the intact animal. Studies with rat liver mitochondria (Wainer, 1964) and the perfused rat liver (Simpson & Freedland, 1975) suggested that cysteine was metabolized primarily by cysteinesulphinateindependent pathways, because addition of unlabelled cysteinesulphinate had relatively little effect on metabolism of radiolabelled cysteine to sulphate or glucose. Furthermore, sulphide was a product of cysteine catabolism in homogenate systems (Stipanuk & Beck, 1982) , and thiosulphate, which may be formed from sulphane sulphur (Koj et al., 1967) , appeared to be a normal intermediate in the production of sulphate from cysteine in the intact rat (Szczepkowski et al., 1961) . No significant production of reduced sulphur should occur via the cysteinesulphinate pathway, because the sulphur of cysteinesulphinate is already oxidized and is either released as SO2 (after transamination of cysteinesulphinate to 3-sulphinylpyruvate) or retained in taurine. A system for reduction of sulphite or sulphate to sulphide does not exist in mammalian tissues (Koj et al., 1967) .
Thus several observations suggest that a substantial portion of cysteine catabolism in the intact rat may occur by cysteinesulphinate-independent pathways that involve the release of reduced sulphur. Production of pyruvate and reduced inorganic sulphur from cysteine can occur by two known pathways of cysteine metabolism in mammalian tissues. These are the cleavage of cyst(e)ine by cystathionase [EC 4.4.1.1; cyst(e) ine desulphhydrase] (Cavallini et al., 1962a,b; Szczepkowski & Wood, 1967; Yamanishi & Tuboi, 1981) and the transamination of cysteine to 3-mercaptopyruvate followed by transsulphuration or desulphuration of 3-mercaptopyruvate (Ubuka et al., 1977a (Ubuka et al., ,b, 1978 .
Because of the conflicting evidence for the metabolism ofcysteine by cysteinesulphinate-dependent and cysteinesulphinate-independent pathways, we have attempted to assess the importance of various pathways in the catabolism of cysteine by freshly isolated rat hepatocytes. (Griffith, 1982; Daniels & Stipanuk, 1982 (Taniguchi & Kimura, 1974; Ip et al., 1977; Ubuka et al., 1977a Ubuka et al., ,b, 1978 . Oxoglutarate is also a good co-substrate for cysteinesulphinate Taurine transamination, which is catalysed by aspartate aminotransferase (Yagi et al., 1979; Recasens et al., 1980) . Hepatocytes were treated with propargylglycine, an irreversible inhibitor of cystathionase (Abeles & Walsh, 1973) , to assess the possible role of cyst(e)ine cleavage by cystathionase in cysteine metabolism. Because propargylglycine also inhibits alanine aminotransferase, the effect of cycloserine (25 #M), which is a more-potent inhibitor of alanine aminotransferase than of aspartate aminotransferase (Cornell et al., 1984) , was also tested. In experiments with inhibitors, hepatocytes were incubated with the inhibitor at 37°C for 20 min before the substrate was added; the substrate solution that was added contained inhibitor at the same concentration as the preincubation mixture.
Two flasks, each of which contained 2.5 ml of incubation mixture and had a plastic centre well suspended from the septum stopper, were used for determination of '4CO2 production. Two other flasks, which each contained 5.0 ml of incubation mixture, were used for determinations of ATP, taurine, hypotaurine, cysteinesulphinate (except when cysteinesulphinate was the substrate), urea, ammonia (NH3 + NH4+), glutamate, glutamine, alanine and aspartate. Flasks were incubated for 0, 10 or 40 min, and incubations were stopped by addition of HCl04 as described previously (De La Rosa et al., 1987) . Production of metabolites was calculated by subtracting the zero-time value from the 10 or 40 min value. Although determinations both of 14CO2 production and of nitrogenous metabolites were initially carried out on the same hepatocyte preparations, problems with purity of the radiolabelled substrates and with experimental procedures in the initial experiments resulted in our repeating all '4C02-production experiments. Thus the C02 data reported in all Tables in this paper were derived from different hepatocyte preparations from those giving the data for production of other metabolites.
We have previously shown (De La Rosa et al., 1987 ) that the capacity of the rat hepatocyte to oxidize either cysteine or cysteinesulphinate is saturated at an exogenous substrate concentration of 25 mm, but not at 1 mm substrate. The rate of production of 14CO2 and of various nitrogenous metabolites from either cysteine or cysteinesulphinate was nearly constant over the 40 min incubation period, and was proportionate to cell concentration between 0 and 30 mg wet wt. of hepatocytes/ml of incubation mixture. All values reported in this paper are for the total incubation period (40 min value minus zero-time value). Effect of enzyme inhibitors on enzyme activities
To determine the effect of enzyme inhibitors (2 mM-DL-propargylglycine and 25 ,sM-cycloserine) on the activities of aspartate aminotransferase, alanine aminotransferase and cystathionase, hepatocytes were incubated with inhibitor for 20 min at 37°C and then washed three times with Krebs-Henseleit buffer as described by Cornell et al. (1984) . The cells were then suspended in Krebs-Henseleit buffer that contained 0.1 % Triton X-100 and kept at 0°C for 90 min with gentle mixing at 30 min intervals; portions of the cell extracts were then assayed for enzyme activity.
Analytical methods
Radioactive CO2 was trapped, measured and used to calculate the rate of conversion of the carboxyl carbon of cysteine or cysteinesulphinate into C02 as previously described (De La Rosa et al., 1987) . Acid supernatants of the reaction mixtures were prepared and treated as previously described for the measurement of various metabolites (De La Rosa et al., 1987) . ATP, glutamine, glutamate, ammonia and urea were measured by enzymic/spectrophotometric methods (Lamprecht & Trautschold, 1974; Lund, 1974; Bernt & Bergmeyer, 1974; Kun & Kearney, 1974; Gutmann & Bergmeyer, 1974) . Hypotaurine, taurine, cysteinesulphinate, alanine and aspartate were analysed by reversed-phase chromatography of their ophthalaldehyde/2-mercaptoethanol derivatives by the method of Hirschberger et al. (1985) . Aspartate aminotransferase (EC 2.6.1.1) and alanine aminotransferase (EC 2.6.1.2) activities were measured as described by Bergmeyer & Bernt (1974a,b) . Cystathionase activity was measured by assaying 2-oxobutyrate production from cystathionine as described by Stipanuk (1979) . The wet weight of cells was determined as previously described (De La Rosa et al., 1987) by using the ratio of wet to dry weight of 3.7 (Krebs et al., 1974 
RESULTS

Metabolism of cysteine and cysteinesulphinate by rat hepatocytes
In experiments with 25 mM-cysteine and 25 mMcysteinesulphinate (Table 1) , both the rate of C02 production from C-1 and the calculated total for the production of nitrogenous metabolites were similar, indicating that both substrates were taken up and metabolized by the rat hepatocytes. When hepatocytes were incubated with cysteine, small amounts of hypotaurine and taurine were produced, and the accumulation of urea and ammonia was much greater than in incubations of hepatocytes without exogenous substrate. In incubations of hepatocytes with cysteinesulphinate, over 10 times as much hypotaurine plus taurine was produced as in incubations with cysteine, whereas the accumulation of urea and ammonia was similar to that in incubations with no substrate. Small differences in the amounts of glutamate and aspartate were also observed between incubations with and without substrate, but metabolism of neither cysteine nor cysteinesulphinate appeared to result in substantial increases in the concentrations of glutamate, aspartate or any other amino acid. Clearly the major nitrogenous products of cysteine metabolism were urea and ammonia, whereas those ofcysteinesulphinate metabolism were hypotaurine and taurine.
Similar studies with 1 mM-cysteine or -cysteinesulphinate in the incubation mixture (results not shown) indicated that C-I ofboth cysteine and cysteinesulphinate was oxidized to CO2, with the rate of CO2 production from cysteinesulphinate (73+18 pmol/min per mg of cells) being 6 times that from cysteine (11 + 2 pmol/min Vol. 244 Addition of 2 mM-2-oxoglutarate increased the oxidation of the carboxy-group C of cysteinesulphinate to CO2 by 3-fold, as shown in Table 2 . A similar effect of 2 mM-2-oxoglutarate was observed in incubations with 1 mM-cysteinesulphinate (results not shown). The increased metabolism ofcysteinesulphinate, presumably by transamination, in the presence of 2-oxoglutarate was accompanied by increased accumulation of amino acids (glutamate, glutamine and alanine), decreased production of ammonia plus urea N, and decreased production of hypotaurine plus taurine.
In contrast with experiments with cysteinesulphinate, addition of 2-oxoglutarate to incubations of hepatocytes with cysteine had no effect on the conversion of the carboxyl carbon of cysteine into CO2 and resulted in only a small increase in the accumulation of glutamate. Addition of 2-oxoglutarate had no effect on the production of any of the nitrogenous metabolites in incubations of hepatocytes without substrate.
Addition of pyruvate (2 mM) had no effect on production of any of the metabolites in incubations of hepatocytes with cysteine or no substrate (results not shown). A 25% decrease in ammonia plus urea N production, a 144% increase in alanine production and a 40% increase in glutamate production were observed when pyruvate was added to incubations of hepatocytes with 25 mM-cysteinesulphinate; these changes may have resulted from transamination of pyruvate with endogenous amino acids. 14CO2 production (from the labelled carboxy-group C), total production of nitrogenous compounds and hypotaurine plus taurine production from cysteinesulphinate were unaffected by addition of pyruvate, which indicates that cysteinesulphinate catabolism was not altered by addition of pyruvate. Effect of propargylglycine and cycloserine on the metabolism of cysteine and cysteinesulphinate by rat hepatocytes Our measurements (Table 3) indicate that incubation of hepatocytes with propargylglycine decreased cystathionase activity to 1 % of the control value, whereas cycloserine had no effect on cystathionase activity.
Both propargylglycine and cycloserine inhibited alanine Table 2 . Effect of addition of 2 mM-2-oxoglutarate to incubation mixtures on the metabolism of cysteine and cysteinesulphinate by hepatocytes Each value is the mean + S.D. for three or four experiments. Hepatocytes from the liver of one rat were used for each experiment. The ATP content in the hepatocytes was > 2.0 ,umol/g wet wt. at both the beginning and the end of the 40 min incubation period in all experiments. Differences between means were accepted as significant at P < 0.05 with the paired t test and are noted as follows: a value is significantly different from corresponding control value (same substrate, no 2-oxoglutarate). Total N is the sum ofammonia + 2(urea) + 2(glutamine) + taurine + hypotaurine + glutamate + alanine + aspartate + cysteinesulphinate (except when it is the substrate). Abbreviations used: 2-OG, 2-oxoglutarate; CYS, cysteine; CSA, cysteinesulphinate. Table 4 . Effect of propargylglycine on the metabolism of cysteine and cysteinesulphinate by hepatocytes Hepatocytes wre incubated with inhibitor for 20 min at 37°C before addition of substrate. Each value is the mean+ S.D. for three experiments. Hepatocytes from the liver of one rat were used for each experiment. The ATP content in the hepatocytes was > 2.0 ,mol/g wet wt. at both the beginning and end of the 40 min incubation period in all experiments. Differences between means were accepted as significant at P < 0.05 with the paired t test and are noted as follows: a value significantly different from corresponding control value (same substrate, no propargylglycine). Total N is the sum of ammonia + 2(urea) + 2(glutamine) + taurine + hypotaurine + glutamate + alanine + aspartate + cysteinesulphinate (except when it is the substrate). Abbreviations used: PG, propargylglycine; CYS, cysteine; CSA, cysteinesulphinate. taurine, whereas they converted cysteine N primarily into urea plus ammonia. We do not know the kinetics of transport of cysteine and cysteinesulphinate, or the intracellular steady-state concentration of cysteinesulphinate in the hepatocytes in the various incubation systems, but it seems unlikely that either factor could explain the grossly different patterns of metabolite production from the two substrates. The similar and substantial production of CO, and of nitrogenous products from 25 mM-cysteine and 25 mM-cysteinesulphinate indicate that both compounds are taken up and metabolized by hepatocytes. Furthermore, over 5 times as much hypotaurine plus taurine was produced in incubations of hepatocytes with 1 mM-cysteinesulphinate as in those with 25 mM-cysteine, despite a much lower rate of total catabolism of substrate in incubations with 1 mM-cysteinesulphinate (73 pmol of CO2/min per mg of cells) than in those with 25 mmcysteine (231 pmol of C02/min per mg).
If we assume that addition of exogenous 25 mMcysteinesulphinate created an effective diluting/trapping pool for any labelled cysteinesulphinate formed from cysteine, the absence of any effect of cysteinesulphinate on 14CO2 production from [1_-4C]cysteine also suggests that little cysteine catabolism occurred via the cysteinesulphinate pathway.
Although cysteinesulphinate itself may be metabolized by either the decarboxylation pathway or the transamination pathway, the decarboxylation pathway, which leads to taurine production, appeared to be the preferred pathway, except in cells incubated with 2-oxoglutarate. The apparent predominance of the decarboxylation pathway is consistent with the relatively low Km of cysteinesulphinate decarboxylase for cysteinesulphinate, 0.045-0.17 mM (Oertel et al., 1981; Guion-Rain et al., 1975) , compared with that of aspartate aminotransferase for cysteinesulphinate, 3-25 mm (Yagi et al., 1979; Recasens et al., 1980) . The efficient conversion of cysteinesulphinate into taurine plus hypotaurine suggests that the cysteinesulphinate pathway may be responsible for taurine formation from cysteine in hepatocytes. The lack of a detectable effect of excess cysteinesulphinate on 14CO2 production from labelled cysteine probably reflects a low flux of cysteine through the cysteinesulphinate pathway, rather than a complete absence of flux.
Estimates of the percentage flux of cysteinesulphinate or cysteine to hypotaurine plus taurine can be made from our data. More than 80% of the estimated overall catabolism of cysteinesulphinate by rat hepatocytes (determined as CO2 production from C-1 of cysteinesulphinate) could be accounted for by accumulation of hypotaurine and taurine. In contrast, less than 10% of cysteine catabolism could be accounted for by hypotaurine plus taurine formation. sulphinate metabolism in hepatocytes incubated without exogenous oxo acid, transamination was the preferred pathway of cysteinesulphinate metabolism when 2 mm-2-oxoglutarate was added to the incubation mixture. In the presence of 2-oxoglutarate, the percentage flux of cysteinesulphinate to taurine plus hypotaurine was decreased to 13 %, which was associated with an increase in total cysteinesulphinate catabolism to 4-fold the control value (as measured by CO, production from C-1) and a decrease in hypotaurine plus taurine production to half the control value. The substantial accumulation of glutamate observed in incubations with both cysteinesulphinate and 2-oxoglutarate is additional evidence that cysteinesulphinate was metabolized via transamination. Apparently, the N of cysteinesulphinate was transferred to the oxo acid to form glutamate (which accumulated with little further metabolism to urea plus ammonia), whereas further metabolism of the carbon chain (as pyruvate) resulted in increased production of 14CO2. However, the increase in glutamate accumulation in incubations with 2-oxoglutarate was 5 times the increase in CO2 production, which suggests that further metabolism of 3-sulphinylpyruvate or pyruvate was incomplete. This may have resulted simply from the increased magnitude of pyruvate production or a block in the pathway after transamination.
Although 2-oxoglutarate and pyruvate have been demonstrated to be good co-substrates for cysteine transamination in vitro, the total rate of cysteine catabolism by rat hepatocytes was not affected by addition of either of these oxo acids to the incubation mixture. Furthermore, the pattern of amino acid production indicated that little transamination ofcysteine with either oxo acid occurred, in contrast with the substantial transamination of cysteinesulphinate with 2-oxoglutarate. This finding that cysteine was not a good substrate for transamination in the intact cell is consistent with the very high Km for cysteine (22 mM) of cysteine aminotransferase (probably aspartate aminotransferase) (Yagi et al., 1979; Recasens et al., 1980; Akagi, 1982) .
Our data indicate that cyst(e)ine cleavage by cystathionase may account for about half of cyst(e)ine catabrolism by hepatocytes. The essentially complete inhibition ofcystathionase by propargylglycine depressed conversion of [1-'4C]cysteine into 14CO2 by about 50%, and decreased the production of ammonia plus urea N in incubations with cysteine to a value not significantly different from that for incubations without substrate. Propargylglycine had no apparent effect on cysteinesulphinate catabolism. The lack of an effect of cycloserine, which inhibited hepatic alanine aminotransferase to a similar extent as did propargylglycine, on either cysteine or cysteinesulphinate metabolism suggests that the effects of propargylglycine on cysteine metabolism were due to inhibition of cystathionase rather than to inhibition of alanine aminotransferase. It is somewhat surprising that propargylglycine had a greater effect on ammonia plus urea N production in incubations with cysteine than on CO2 production. It is possible that an unknown effect of ptopargylglycine, direct or indirect, caused a decrease in the flux of cysteine N to urea or ammonia or an increase in the oxidation of C-I of pyruvate to CO2.
In conclusion, these studies of cysteine metabolism in rat hepatocytes suggest that not more than about 10% of hepatic cysteine catabolism involves intermediate formation of cysteinesulphinate or results in production of hypotaurine plus taurine. We do not know whether the much higher estimates of taurine production from cysteine that were obtained for intact rats (Yamaguchi et al., 1973; Stipanuk & Rotter, 1984) were based on false assumptions, and are therefore incorrect, or if metabolism of cysteine by hepatocytes is not representative of cysteine metabolism in the whole animal. The accumulation of urea plus ammonia in incubations of hepatocytes with cysteine indicated that cysteine was metabolized primarily by a transamination or deamination reaction. Direct transamination of cysteine did not seem to play a major role in cysteine catabolism, but the cyst(e)inecleavage reaction catalysed by cystathionase appeared to account for about 50% of total cyst(e)ine catabolism.
Further studies of cysteine metabolism in liver as well as other tissues are needed to elucidate further the roles of various pathways of cysteine metabolism.
